clinical trials
years duration
greater reduction in forced expiratory volume
fev
patients
inhaled insulin
decline in patients
receiving comparator
anti-diabetes treatment
patients with chronic lung disease
studies
fev decline
first months
increased duration of use
changes in fev
patients with type
type diabetes mellitus
cough
bronchitis
productive cough
pulmonary function test
hypoglycemia
hypoglycemia
diabetic ketoacidosis frequency
weight gain
diabetic
patients with type diabetes
diabetic ketoacidosis
n
patients
inhaled insulin
n =-rrb- of patients
receiving subcutaneous insulin
hypoglycemia
incidence of non-severe hypoglycemia in patients with type diabetes
incidence of severe hypoglycemia
severe episode
hypoglycemic event
requiring assistance of another person
blood glucose value
hypoglycemia
prompt recovery
following treatment
non-severe episode
symptoms of hypoglycemia
low blood glucose value
incidence of hypoglycemia
patients with type diabetes
weight gain
patients with type diabetes mellitus
inhaled insulin therapy
mean weight gain of kg
mean weight loss of kg in placebo-treated patients
diarrhea
nausea
common adverse reactions
hypoglycemia
cough
throat pain
irritation
common reason for drug discontinuation
cough
throat pain
irritation
urinary tract infection
clinical trials
cases of lung cancer
cases
heavy tobacco use
following completion of clinical trials
cases of squamous cell lung cancer
non-smokers
frequency
lung cancer
fatigue
headache
anxiety
blurred vision
chills
cold sweats
coma
confusion
cool, pale skin
cough
depression
dizziness
fast heartbeat
headache
increased hunger
nausea
nightmares
seizures
shakiness
slurred speech
unusual tiredness
weakness
difficulty breathing
difficulty swallowing
hives
itching
skin rash
noisy breathing
puffiness
swelling of the eyelids
eyes
face
lips
tongue
tightness in the chest
diarrhea
sore throat
weight gain